Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Müller-Ehmsen

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Herz|July 25, 2013
[Sleep apnea and heart failure]T Plenge, J Müller-Ehmsen
Der Internist|January 7, 2017
[Vitamin K antagonists : Is their prescription really "medical malpractice" today?]E Rafflenbeul, J Müller-Ehmsen
Journal of Cardiovascular Pharmacology|May 21, 1998
Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardiumJ Müller-Ehmsen, K Brixius, R H Schwinger
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
Na+-channel modulating effect of the inotropic compound S(-)BDF 9196 in human myocardiumJ Müller-Ehmsen, M Näbauer, R H Schwinger
British Journal of Clinical Pharmacology|April 1, 1997
Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardiumJ Müller-Ehmsen, K Frank, K Brixius, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardiumR H Schwinger, J Müller-Ehmsen, M Böhm, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissueJ Müller-Ehmsen, K Brixius, S Hoischen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1997
Na+ channel modulation and force-frequency relationship in human myocardiumJ Müller-Ehmsen, K Brixius, C Schulze, et al.
Deutsche Medizinische Wochenschrift (1946)|February 9, 2011
[Epileptic seizures: effects on cardiac function]L Burghaus, G R Fink, E Erdmann, et al.
Gene Therapy|March 16, 2012
Percutaneous methods of vector delivery in preclinical modelsD Ladage, K Ishikawa, L Tilemann, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Herz|July 25, 2013
[Sleep apnea and heart failure]T Plenge, J Müller-Ehmsen
Der Internist|January 7, 2017
[Vitamin K antagonists : Is their prescription really "medical malpractice" today?]E Rafflenbeul, J Müller-Ehmsen
Journal of Cardiovascular Pharmacology|May 21, 1998
Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardiumJ Müller-Ehmsen, K Brixius, R H Schwinger
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
Na+-channel modulating effect of the inotropic compound S(-)BDF 9196 in human myocardiumJ Müller-Ehmsen, M Näbauer, R H Schwinger
British Journal of Clinical Pharmacology|April 1, 1997
Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardiumJ Müller-Ehmsen, K Frank, K Brixius, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1996
Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardiumR H Schwinger, J Müller-Ehmsen, M Böhm, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissueJ Müller-Ehmsen, K Brixius, S Hoischen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1997
Na+ channel modulation and force-frequency relationship in human myocardiumJ Müller-Ehmsen, K Brixius, C Schulze, et al.
Deutsche Medizinische Wochenschrift (1946)|February 9, 2011
[Epileptic seizures: effects on cardiac function]L Burghaus, G R Fink, E Erdmann, et al.
Gene Therapy|March 16, 2012
Percutaneous methods of vector delivery in preclinical modelsD Ladage, K Ishikawa, L Tilemann, et al.
Pageof 4